• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于延长植入式端口维护冲洗间隔的II期试验。

Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports.

作者信息

Diaz Jorge A, Rai Shesh N, Wu Xiaoyoung, Chao Ju-Hsien, Dias Ajoy L, Kloecker Goetz H

机构信息

University of Louisville James Graham Brown Cancer Center, Louisville, KY.

出版信息

J Oncol Pract. 2017 Jan;13(1):e22-e28. doi: 10.1200/JOP.2016.010843. Epub 2016 Oct 23.

DOI:10.1200/JOP.2016.010843
PMID:28084883
Abstract

PURPOSE

Retrospective studies suggest that it may be safe to extend the maintenance flushing interval of implanted ports from once every month, as recommended by the manufacturer, to once every 3 months, but no prospective cohort studies have been done specifically assessing the safety and feasibility of this intervention.

METHODS

This was a phase II study in oncologic patients who retained a functional port after completion of systemic chemotherapy. Patients enrolled in the study had their port flushed once every 3 months and were observed until completion of five scheduled flushes (one on enrollment and four additional flushes, one every 3 months) or development of any port-related complication, including infections, thrombosis, and occlusions. The primary end points were frequency of port-related complications and port failure requiring removal.

RESULTS

A total of 87 patients were enrolled in the study. The median follow-up time was 308 days, accounting for a total of 24,202 catheter-days. There were 10 port-related complications (11.49%; 95% CI, 4.85% to 18.14%). No infection or symptomatic thrombosis occurred. The mean time to port-related complication was 184 days. No patients developed port failure while on protocol, but on subsequent medical record review, four patients developed a complication that required port removal or port revision within 30 days of being removed from the trial (4.6%; 95% CI, 0.4% to 8.8%; 0.17/1,000 catheter-days).

CONCLUSION

Extending the maintenance flushes of implanted ports in adult oncologic patients to once every 3 months is safe, effective, and likely to increase patient adherence and satisfaction while decreasing the associated cost.

摘要

目的

回顾性研究表明,将植入式端口的维护冲洗间隔从制造商推荐的每月一次延长至每三个月一次可能是安全的,但尚未进行专门评估这种干预措施安全性和可行性的前瞻性队列研究。

方法

这是一项针对全身化疗完成后保留功能性端口的肿瘤患者的II期研究。纳入该研究的患者每三个月对其端口进行一次冲洗,并进行观察,直至完成五次预定冲洗(一次在入组时,另外四次冲洗,每三个月一次)或出现任何与端口相关的并发症,包括感染、血栓形成和堵塞。主要终点是与端口相关的并发症发生率和需要移除的端口故障情况。

结果

共有87名患者纳入该研究。中位随访时间为308天,总计24202导管日。发生了10例与端口相关的并发症(11.49%;95%CI,4.85%至18.14%)。未发生感染或有症状的血栓形成。与端口相关并发症的平均发生时间为184天。在方案执行期间,没有患者出现端口故障,但在随后的病历审查中,有4名患者在退出试验后30天内出现了需要移除端口或对端口进行修复的并发症(4.6%;95%CI,0.4%至8.8%;0.17/1000导管日)。

结论

将成年肿瘤患者植入式端口的维护冲洗延长至每三个月一次是安全、有效的,并且可能会提高患者的依从性和满意度,同时降低相关成本。

相似文献

1
Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports.关于延长植入式端口维护冲洗间隔的II期试验。
J Oncol Pract. 2017 Jan;13(1):e22-e28. doi: 10.1200/JOP.2016.010843. Epub 2016 Oct 23.
2
Current port maintenance strategies are insufficient: View based on actual presentations of implanted ports.当前的端口维护策略并不充分:基于植入端口的实际表现的观点。
Medicine (Baltimore). 2019 Nov;98(44):e17757. doi: 10.1097/MD.0000000000017757.
3
Is There a Relationship Between Frequency of Port-Care Maintenance and Related Complications in Patients With Cancer?癌症患者的端口维护频率与相关并发症之间是否存在关系?
JCO Oncol Pract. 2022 Sep;18(9):e1438-e1446. doi: 10.1200/OP.22.00060. Epub 2022 Jun 7.
4
Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.用于前臂植入式中心静脉导管装置的聚氨酯导管与硅胶导管的比较
Eur J Cancer. 2016 May;59:113-124. doi: 10.1016/j.ejca.2016.02.011. Epub 2016 Mar 26.
5
Right- versus Left-Sided Chest Ports in Oncologic Patients with a History of Right-Sided Port Removal: Are There Any Differences in the Complication Rates?右侧胸部端口与左侧胸部端口在有右侧端口移除史的肿瘤患者中的应用:并发症发生率是否存在差异?
J Vasc Interv Radiol. 2019 May;30(5):726-733. doi: 10.1016/j.jvir.2019.01.008. Epub 2019 Mar 27.
6
Incidence and Determinants of Port Occlusions in Cancer Outpatients: A Prospective Cohort Study.癌症门诊患者门静脉闭塞的发生率及影响因素:一项前瞻性队列研究。
Cancer Nurs. 2017 Mar/Apr;40(2):102-107. doi: 10.1097/NCC.0000000000000357.
7
Radiologic placement of a low profile implantable venous access port in a pediatric population.小儿人群中低调可植入式静脉通路端口的放射学放置
Cardiovasc Intervent Radiol. 2001 Nov-Dec;24(6):395-9. doi: 10.1007/s00270-001-0071-1. Epub 2001 Nov 8.
8
Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.完全植入式静脉通路端口系统的并发症相关移除:放置与首次使用之间的间隔以及化疗方案诱导中性粒细胞减少的可能性是否会影响其发生率?一项针对4045例患者的四年前瞻性研究。
Eur J Surg Oncol. 2017 Apr;43(4):689-695. doi: 10.1016/j.ejso.2016.10.020. Epub 2016 Nov 5.
9
Complications of PORT-A-CATH® in patients with sickle cell disease.镰状细胞病患者 PORT-A-CATH®的并发症。
J Infect Public Health. 2012 Mar;5(1):57-62. doi: 10.1016/j.jiph.2011.10.004. Epub 2011 Dec 6.
10
Use of port-a-cath in cancer patients: a single-center experience.癌症患者中植入式静脉输液港的应用:单中心经验
J Infect Dev Ctries. 2014 Nov 13;8(11):1476-82. doi: 10.3855/jidc.4155.

引用本文的文献

1
Is it feasible to prolong the flushing interval for totally implantable venous access devices (TIVADs)? A systematic review and meta-analysis.延长完全植入式静脉通路装置(TIVADs)的冲洗间隔是否可行?一项系统评价和荟萃分析。
Int J Clin Oncol. 2025 Jan;30(1):40-50. doi: 10.1007/s10147-024-02665-2. Epub 2024 Nov 27.
2
Complications associated with the removal of totally implantable venous access devices (TIVADs): a retrospective analysis of 4,954 breast cancer patients in a single institution.完全植入式静脉输液港(TIVAD)取出相关并发症:单中心 4954 例乳腺癌患者的回顾性分析。
BMC Surg. 2024 Oct 22;24(1):324. doi: 10.1186/s12893-024-02630-w.
3
Disparities in Clinical Trial Participation: A Cross-Sectional Survey of Cancer Patients at a Midwest Academic Medical Center.
临床试验参与中的差异:中西部学术医疗中心癌症患者的横断面调查。
Curr Oncol. 2024 Sep 11;31(9):5367-5373. doi: 10.3390/curroncol31090396.
4
Focused ultrasound enables selective actuation and Newton-level force output of untethered soft robots.聚焦超声使非束缚软体机器人能够进行选择性驱动和牛顿级别的力输出。
Nat Commun. 2024 Jun 18;15(1):5197. doi: 10.1038/s41467-024-49148-6.
5
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.肿瘤学中中央静脉通路装置的术语、并发症和移除原因:范围综述。
BMC Cancer. 2024 Apr 19;24(1):498. doi: 10.1186/s12885-024-12099-8.
6
Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer.乳腺癌患者非治疗阶段完全植入式静脉输液港冲管间隔延长的安全性与可行性评估
Front Oncol. 2022 Dec 2;12:1021488. doi: 10.3389/fonc.2022.1021488. eCollection 2022.
7
Is There a Relationship Between Frequency of Port-Care Maintenance and Related Complications in Patients With Cancer?癌症患者的端口维护频率与相关并发症之间是否存在关系?
JCO Oncol Pract. 2022 Sep;18(9):e1438-e1446. doi: 10.1200/OP.22.00060. Epub 2022 Jun 7.
8
A retrospective observational study on maintenance and complications of totally implantable venous access ports in 563 patients: Prolonged versus short flushing intervals.一项关于563例患者完全植入式静脉输液港维护及并发症的回顾性观察研究:延长冲洗间隔与缩短冲洗间隔的比较
Int J Nurs Sci. 2021 Jun 4;8(3):252-256. doi: 10.1016/j.ijnss.2021.05.005. eCollection 2021 Jul 10.
9
Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic.癌症还是新冠疫情?大流行之后安全癌症护理指南综述。
SN Compr Clin Med. 2020;2(12):2691-2701. doi: 10.1007/s42399-020-00632-2. Epub 2020 Nov 21.
10
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.COVID-19 疫情期间胃肠道癌症患者的全身治疗:米兰国家癌症研究所的 COVID-19 适应推荐意见。
Clin Colorectal Cancer. 2020 Sep;19(3):156-164. doi: 10.1016/j.clcc.2020.05.004. Epub 2020 May 23.